Premium
6‐Hydroxydopamine Lesions of the Locus Coeruleus Induce a Paradoxical Increase in Growth Hormone Secretion in Male Rats
Author(s) -
BluetPajot M. T.,
Mounier F.,
Durand D.,
Kordon C.,
LlorensCortes C.,
Videau C.,
Epelbaum J.
Publication year - 1992
Publication title -
journal of neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.062
H-Index - 116
eISSN - 1365-2826
pISSN - 0953-8194
DOI - 10.1111/j.1365-2826.1992.tb00338.x
Subject(s) - locus coeruleus , endocrinology , medicine , prolactin , galanin , hypothalamus , hormone , lesion , chemistry , biology , neuropeptide , central nervous system , receptor , psychiatry
Abstract While the pharmacology of noradrenaline effects on growth hormone (GH) secretion has been extensively studied, the precise localization of noradrenergic neurons involved remains unclear. In the present work, we investigated whether A6 noradrenergic neurons located in the locus coeruleus can play a role in the rhythmic pattern of GH secretion or in the sensitivity of the hormone response to different external challenges. Three weeks after bilateral 6‐hydroxydopamine injections (8μg/3μl) into the locus coeruleus, hypothalamic noradrenaline concentrations were reduced by 60%. Pulsatile GH secretory patterns were observed in unanaesthetized, freely moving control, sham‐operated or locus coeruleus‐lesioned male rats. The amplitude of the pulses and the area under the curves during the 6‐ or 12‐h sampling period were twice as high in locus coeruleus‐lesioned than in control and sham‐operated rats. In contrast, trough levels of GH and intervals between GH peaks were similar in all groups. Prolactin, adrenocorticotrophin, thyroid‐stimulating hormone and luteinizing hormone plasma levels were not affected by the lesion. GH responses to two centrally acting drugs i.e. clonidine (2.5, 5 and 10μg/100g body wt) and morphine (200μg/100g body wt) were also highly amplified in locus coeruleus‐lesioned rats. In contrast, GH responses to two peptides directly acting on somatotrophs i.e. GH‐releasing factor (0.05 and 1.25μg/100g body wt) and vasoactive intestinal peptide (1.5μg/100g body wt) were the same in sham‐operated and lesioned animals. These data suggest that noradrenergic inputs from the locus coeruleus exert a selective inhibitory influence on GH secretion through centrally mediated mechanisms.